Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283608 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Adel B Elmoselhi und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Sharjah, Sharjah, UAE. Hauptthemen laut MEDLINE: Circulating MicroRNA, MicroRNAs, Vitamin D Deficiency, Diabetes Mellitus. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences.
Abstract (Originalsprache)
Vitamin D3 deficiency, obesity, and diabetes mellitus (DM) have been shown to increase the risk of cardiovascular diseases (CVDs). However, the early detection of vascular damage in those patients is still difficult to ascertain. MicroRNAs (miRNAs) are recognized to play a critical role in initiation and pathogenesis of vascular dysfunction. Herein, we aimed to identify circulating miRNA biomarkers of vascular dysfunction as early predictors of CVDs. We have recruited 23 middle-aged Emiratis patients with the following criteria: A healthy control group with vitamin D ≥ 20ng, and BMI < 30 ( C1 group = 11 individuals ); A vitamin D deficiency (Vit D level ≤ 20 ng) and obese (BMI ≥ 30) group ( A1 group = 9 patients ); A vitamin D deficiency, obese, plus DM ( A2 group = 3 patients ). Arterial stiffness via pulse wave velocity (PWV) was measured and the whole transcriptome analysis with qPCR validation for miRNA in plasma samples were tested. PWV relative to age was significantly higher in A1 group 19.4 ± 4.7 m/s and A2 group 18.3 ± 1.3 m/s compared to controls 14.7 ± 2.1 m/s (p < 0.05). Similar patterns were also observed in the Augmentation pressure (AP) and Alx%. Whole RNA-Sequencing revealed miR-182-5p; miR-199a-5p; miR-193a-5p; and miR-155-5p were differentially over-expressed (logFC > 1.5) in high-risk patients for CVDs vs healthy controls. Collectively, our result indicates that four specific circulating miRNA signature, may be utilized as non-invasive, diagnostic and prognostic biomarkers for early vascular damage in patients suffering from vitamin D deficiency, obesity and DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Medicine, University of Sharjah, Sharjah, UAE.
- Sharjah Institute of Medical Research, College of Medicine, University of Sharjah, Sharjah, UAE.
- Cardiology Department, University Hospital Sharjah, Sharjah, UAE.
- College of Arts and Sciences, American University of Sharjah, University City, Sharjah, UAE.
ORCID-Profile: Adel B Elmoselhi, Rifat A Hamoudi
Förderung
- Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences
Zitieren
APA
Elmoselhi, A. B., Seif Allah, M., Bouzid, A., Ibrahim, Z., Venkatachalam, T., Siddiqui, R., Khan, N. A., & Hamoudi, R. A. (2023). Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0283608
Vancouver
Elmoselhi AB, Seif Allah M, Bouzid A, Ibrahim Z, Venkatachalam T, Siddiqui R, et al. Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients. PLOS ONE. 2023. doi:10.1371/journal.pone.0283608
BibTeX
@article{Elmoselhi2023,
author = {Elmoselhi, Adel B and Seif Allah, Mohamed and Bouzid, Amal and Ibrahim, Zeinab and Venkatachalam, Thenmozhi and Siddiqui, Ruqaiyyah and Khan, Naveed Ahmed and Hamoudi, Rifat A},
title = {Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283608}
}
EUVIMED